Back to Search Start Over

A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain

Authors :
Wallace, M. S.
Rowbotham, M. C.
Katz, N. P.
Dworkin, R. H.
Dotson, R. M.
Galer, B. S.
Rauck, R. L.
Backonja, M. M.
Quessy, S. N.
Meisner, P. D.
Source :
Neurology (Ovid); December 2002, Vol. 59 Issue: 11 p1694-1700, 7p
Publication Year :
2002

Abstract

Nerve injury results in increases in spinal glutamate, which opens the NMDA ionophore channel, causing an influx of calcium. A glycine-binding site must be occupied for the channel to open. GV196771 is a selective antagonist of the glycine-binding site of the NMDA ionophore.

Details

Language :
English
ISSN :
00283878 and 1526632X
Volume :
59
Issue :
11
Database :
Supplemental Index
Journal :
Neurology (Ovid)
Publication Type :
Periodical
Accession number :
ejs49028528